advertisement
Foster PJ 50
Showing records 1 to 25 | Display all abstracts from Foster PJ109233 Association of Systemic Medication Use with Glaucoma and Intraocular Pressure: The European Eye Epidemiology Consortium
Vergroesen JE
Ophthalmology 2023; 130: 893-906
109613 The Association of Physical Activity with Glaucoma and Related Traits in the UK Biobank
Madjedi KM
Ophthalmology 2023; 130: 1024-1036
109422 Iris volume change with physiologic mydriasis to identify development of angle closure: the Zhongshan Angle Closure Prevention Trial
Liao C
British Journal of Ophthalmology 2024; 108: 366-371
109808 Towards modifying the genetic predisposition for glaucoma: An overview of the contribution and interaction of genetic and environmental factors
Stuart KV
Molecular aspects of medicine 2023; 93: 101203
109183 Biometric Risk Factors for Angle Closure Progression After Laser Peripheral Iridotomy
Bao YK; Xu BY
JAMA ophthalmology 2023; 141: 516-524
109422 Iris volume change with physiologic mydriasis to identify development of angle closure: the Zhongshan Angle Closure Prevention Trial
Quigley H
British Journal of Ophthalmology 2024; 108: 366-371
109233 Association of Systemic Medication Use with Glaucoma and Intraocular Pressure: The European Eye Epidemiology Consortium
Schuster AK
Ophthalmology 2023; 130: 893-906
109613 The Association of Physical Activity with Glaucoma and Related Traits in the UK Biobank
Stuart KV
Ophthalmology 2023; 130: 1024-1036
109808 Towards modifying the genetic predisposition for glaucoma: An overview of the contribution and interaction of genetic and environmental factors
Pasquale LR
Molecular aspects of medicine 2023; 93: 101203
109613 The Association of Physical Activity with Glaucoma and Related Traits in the UK Biobank
Chua SYL
Ophthalmology 2023; 130: 1024-1036
109808 Towards modifying the genetic predisposition for glaucoma: An overview of the contribution and interaction of genetic and environmental factors
Kang JH
Molecular aspects of medicine 2023; 93: 101203
109233 Association of Systemic Medication Use with Glaucoma and Intraocular Pressure: The European Eye Epidemiology Consortium
Stuart KV
Ophthalmology 2023; 130: 893-906
109422 Iris volume change with physiologic mydriasis to identify development of angle closure: the Zhongshan Angle Closure Prevention Trial
Jiang Y
British Journal of Ophthalmology 2024; 108: 366-371
109183 Biometric Risk Factors for Angle Closure Progression After Laser Peripheral Iridotomy
Friedman DS
JAMA ophthalmology 2023; 141: 516-524
109808 Towards modifying the genetic predisposition for glaucoma: An overview of the contribution and interaction of genetic and environmental factors
Foster PJ
Molecular aspects of medicine 2023; 93: 101203
109422 Iris volume change with physiologic mydriasis to identify development of angle closure: the Zhongshan Angle Closure Prevention Trial
Huang S
British Journal of Ophthalmology 2024; 108: 366-371
109233 Association of Systemic Medication Use with Glaucoma and Intraocular Pressure: The European Eye Epidemiology Consortium
Asefa NG
Ophthalmology 2023; 130: 893-906
109183 Biometric Risk Factors for Angle Closure Progression After Laser Peripheral Iridotomy
Cho A
JAMA ophthalmology 2023; 141: 516-524
109613 The Association of Physical Activity with Glaucoma and Related Traits in the UK Biobank
Ramulu PY
Ophthalmology 2023; 130: 1024-1036
109422 Iris volume change with physiologic mydriasis to identify development of angle closure: the Zhongshan Angle Closure Prevention Trial
Huang W
British Journal of Ophthalmology 2024; 108: 366-371
109613 The Association of Physical Activity with Glaucoma and Related Traits in the UK Biobank
Warwick A
Ophthalmology 2023; 130: 1024-1036
109808 Towards modifying the genetic predisposition for glaucoma: An overview of the contribution and interaction of genetic and environmental factors
Khawaja AP
Molecular aspects of medicine 2023; 93: 101203
109183 Biometric Risk Factors for Angle Closure Progression After Laser Peripheral Iridotomy
Foster PJ
JAMA ophthalmology 2023; 141: 516-524
109233 Association of Systemic Medication Use with Glaucoma and Intraocular Pressure: The European Eye Epidemiology Consortium
Cougnard-Grégoire A
Ophthalmology 2023; 130: 893-906
109422 Iris volume change with physiologic mydriasis to identify development of angle closure: the Zhongshan Angle Closure Prevention Trial
Friedman D
British Journal of Ophthalmology 2024; 108: 366-371
